Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Codexis: Q4 Earnings Snapshot

Codexis: Q4 Earnings Snapshot

CDXS : 2.80 (-3.45%)
Codexis: Q3 Earnings Snapshot

Codexis: Q3 Earnings Snapshot

CDXS : 2.80 (-3.45%)
Codexis: Q2 Earnings Snapshot

Codexis: Q2 Earnings Snapshot

CDXS : 2.80 (-3.45%)
Codexis (CDXS) Reports Q1 Loss, Lags Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 2.80 (-3.45%)
CTMX : 1.6300 (-2.98%)
Codexis: Q1 Earnings Snapshot

Codexis: Q1 Earnings Snapshot

CDXS : 2.80 (-3.45%)
Will Alimera Sciences (ALIM) Report Negative Q1 Earnings? What You Should Know

Alimera Sciences (ALIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALIM : 3.63 (+1.11%)
CDXS : 2.80 (-3.45%)
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?

Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDXS : 2.80 (-3.45%)
EDIT : 5.35 (-2.01%)
Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 2.80 (-3.45%)
PLRX : 11.90 (-4.95%)
Codexis: Q4 Earnings Snapshot

Codexis: Q4 Earnings Snapshot

CDXS : 2.80 (-3.45%)
How Much Upside is Left in Codexis (CDXS)? Wall Street Analysts Think 219%

The consensus price target hints at a 219.4% upside potential for Codexis (CDXS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

CDXS : 2.80 (-3.45%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar